P0DOX5 (IGG1_HUMAN) Homo sapiens (Human)
Immunoglobulin gamma-1 heavy chain UniProtKBInterProInteractive Modelling
449 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
89 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal structure of IgG1-Fc fragment (E382S) in complex with Corynebacterial ENGase CU43 (D187A-E1… |
Heteromer A0AAN0UME2; | 99.51 | ||||
| Structure of Bevacizumab Fab mutant in complex with VEGF |
Heteromer P15692; Q8TCD0; | 66.13 | 2×SO4; 2×MES; | |||
| Crystal Structure of a Broadly Neutralizing Anti-HIV-1 Antibody in Complex with a Peptide Mimotope |
Heteromer P01834; | 60.71 | 8×GOL; 4×SO4; 1×CXS; 1×K; | |||
| Bovine Fab 2G3 |
Heteromer P0DOY2; | 51.92 | 3×GOL; 1×MES; | |||
| Bovine Fab 5C1 |
Heteromer P0DOY2; | 51.92 | 3×GOL; 1×PO4; | |||
| Bovine Fab 4C1 |
Heteromer P0DOY2; | 51.92 | 2×PO4; | |||
| Cryo-EM structure of Her2 extracellular domain-Trastuzumab Fab-Pertuzumab Fab complex |
Heteromer P01834; P04626; Q6GMX6; | 83.33 | 1×NAG; 5×NAG; | |||
| Structure of a mutant Cetuximab Fab fragment |
Heteromer Q8TCD0; | 60.78 | 3×SO4; 5×GOL; | |||
| human GIPR ECD and Fab complex |
Heteromer P48546; V9HW34; | 79.59 | ||||
| Crystal structure of maltose bound MBP with a conformationally specific synthetic antigen binder (s… |
Heteromer P0AEX9; Q8TCD0; | 76.29 | 1×GLC; 2×IMD; 2×GOL; | |||
| Anti-HIV-1 Fab 2G12 re-refinement |
Heteromer P0DOX7; | 54.21 | 5×SO4; | |||
| Crystal structure of crenezumab Fab |
Heteromer Q0KKI6; | 73.47 | 11×SO4; 2×MES; 2×EPE; | |||
| Anti-HIV-1 Fab 2G12 + Man5 re-refinement |
Heteromer P0DOX7; | 54.21 | 2×BMA; | |||
| Anti-HIV-1 Fab 2G12 + Man1-2 re-refinement |
Heteromer P0DOX7; | 54.21 | 1×MAN; 1×BEZ; 1×GOL; 1×MAN; | |||
| Bovine Fab 2F12 |
Heteromer P0DOY2; | 48.08 | ||||
| Crystal structure of DH1346 Fab in complex with HIV proximal MPER peptide |
Heteromer P04578; | 75.0 | 6×NA; 1×F; | |||
| Crystal structure of crenezumab Fab in complex with Abeta |
Heteromer P05067; Q0KKI6; | 73.47 | ||||
| Anti-HIV-1 Fab 2G12 + Man9 re-refinement |
Heteromer P0DOX7; | 54.21 | 2×NAG; | |||
| RBD in complex with Fab14 |
Heteromer P0DTC2; | 72.73 | 1×NAG; | |||
| VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure |
Heteromer Q2N0S6; Q2N0S7; Q6N089; Q6P5S8; Q8N5F4; | 43.88 | 27×NAG; 3×NAG; 3×NAG; 3×NAG; 21×NAG; | |||
| 3-25 Fab germline-reversion variant bound to an HCMV gB-derived peptide |
Heteromer P06473; P0DOX7; | 89.04 | 1×TRS; 1×PEG; | |||
| Anti-HIV-1 Fab Fab 2G12 + Man4 re-refinement |
Heteromer P0DOX7; | 54.21 | 2×MAN; 8×UNX; 2×ACT; | |||
| Anti-HIV-1 Fab 2G12 + Man7 re-refinement |
Heteromer P0DOX7; | 54.21 | 2×BMA; | |||
| Structure of Monomeric Interleukin-10 Grafted into and Antibody CDR |
Heteromer P22301; | 44.44 | 1×ACT; 1×EDO; | |||
| Crystal structure of the SF12 Fab |
Heteromer Q8TCD0; | 72.15 | ||||
| Structure of Cetuximab Fab mutant in complex with EGFR extracellular domain |
Heteromer P00533; Q8TCD0; | 60.78 | 1×NAG; 1×NAG; 3×NAG; | |||
| Cryo-EM structure of human insulin degrading enzyme in complex with FAB H11 heavy chain and FAB H11… |
Heteromer P14735; Q6GMX0; | 75.44 | ||||
| Cryo-EM structure of human insulin degrading enzyme in complex with FAB H11-E heavy chain, FAB H11-… |
Heteromer P0DOX7; P14735; | 75.44 | ||||
| Cryo-EM structure of human insulin degrading enzyme in complex with FAB H11-E heavy chain, FAB H11-… |
Heteromer P01308; P14735; Q6GMX0; | 75.44 | ||||
| Cryo-EM structure of human insulin degrading enzyme in complex with FAB H11-E heavy chain, FAB H11-… |
Heteromer P0DOX7; P14735; | 75.44 | ||||
| Crystal structure of human Fab PGT124, a broadly neutralizing and potent HIV-1 neutralizing antibody |
Heteromer P0DOY3; | 47.17 | 3×GOL; | |||
| Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neut… |
Heteromer B9V0E2; Q6PIL8; | 75.83 | 1×NAG; 3×NAG; | |||
| Crystal Structure of PGT124 Fab bound to HIV-1 JRCSF gp120 core and to CD4 |
Heteromer P01730; P0DOY3; P20871; | 49.02 | 1×NAG; 8×NAG; 1×CL; 1×GOL; | |||
| Bovine Fab SKD in complex with Sars COV-2 receptor binding domain |
Heteromer P0DOY2; P0DTC2; | 50.98 | 1×NAG; | |||
| Crystal structure of the complex between afucosylated/galactosylated human IgG1 Fc and Fc gamma rec… |
Heteromer P08637; | 100.0 | 2×NAG; 5×EDO; 4×PEG; 9×NA; 2×NAG; | |||
| Structure of Trastuzumab Fab mutant in complex with Her2 extracellular domain |
Heteromer P04626; Q7Z3Y4; | 70.69 | 1×NAG; | |||
| BG505 SOSIP.664 in complex with broadly neutralizing antibodies PG9 and 8ANC195 |
Heteromer Q2N0S6; Q6GMW3; Q8TCD0; S6B291; | 82.46 | ||||
| N123-VRC34.05 HIV neutralizing antibody in complex with HIV fusion peptide residue 512-519 |
Heteromer P04578; Q6GMX0; | 70.33 | ||||
| Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neut… |
Heteromer B9V0E2; Q8TCD0; | 50.0 | 4×NAG; | |||
| Model of gC1q-Fc complex based on 7A EM map |
Heteromer P02745; P02746; P02747; | 100 | ||||
| Crystal structure of fucosylated IgG1 Fc complexed with bis-glycosylated soluble form of Fc gamma r… |
Heteromer P08637; | 100 | 2×NAG; 1×NAG; 1×NAG; 1×CL; | |||
| Crystal structure of fucosylated IgG Fc Y296W mutant complexed with bis-glycosylated soluble form o… |
Heteromer P08637; | 99.53 | 2×NAG; 1×NAG; 1×CL; 1×NAG; | |||
| Crystal structure of the low affinity Fc gamma receptor IIIA variant in complex with the Fc of IgG1. |
Heteromer P08637; | 100 | 2×NAG; 2×NAG; | |||
| Crystal structure of human IgG-Fc in complex with aglycan and optimized Fc gamma receptor IIIa |
Heteromer P08637; | 100 | 1×NAG; 1×NAG; 1×CL; | |||
| Glycosylated FCGR3B / CD16b in complex with afucosylated IgG1 Fc |
Heteromer O75015; | 100 | 1×NAG; 1×NAG; 2×NAG; | |||
| Crystal structure of VEGF in complex with heterodimeric Fcab JanusCT6 |
Heteromer P15692; | 98.09 | 2×NAG; 1×MAN; 1×NAG; 10×MPD; 1×MRD; 2×CAC; 1×TRS; | |||
| GLYCOSYLATED KNOB/DUMMY-HOLE/DUMMY FC FRAGMENT |
Heteromer | 100 | 2×NAG; | |||
| Fc in complex with engineered calcium binding domain Z |
Heteromer A0A0U3TLJ6; | 99.04 | 2×NAG; 5×PEG; 7×GOL; 2×CA; 5×CL; | |||
| Endoglycosidase S2 in complex with IgG1 Fc |
Heteromer T1WGN1; | 98.56 | 1×NAG; 1×NAG; 4×GOL; 5×PGE; 3×CA; | |||
| GLYCOSYLATED KNOB/DUMMY-HOLE FC FRAGMENT |
Heteromer P01857; | 100 | 2×NAG; | |||
| GLYCOSYLATED KNOB-HOLE/DUMMY FC FRAGMENT |
Heteromer | 99.15 | 2×NAG; | |||
| Crystal structure of an IgM rheumatoid factor YES8c in complex with IgG1 Fc |
Heteromer | 100 | 1×NAG; | |||
| The complex structure of Human IgG Fc and its binding Repebody |
Heteromer | 100.0 | 2×NAG; | |||
| BEAT Fc with improved heterodimerization (Q3A-D84.4Q) |
Heteromer P01857; P01860; | 93.24 | 2×NAG; | |||
| Endoglycosidase S in complex with IgG1 Fc |
Heteromer Q99Y92; | 98.55 | 1×NAG; | |||
| cryoEM structure of the catalytically inactive EndoS from S. pyogenes in complex with the Fc region… |
Heteromer Q99Y92; | 100 | 1×NAG; | |||
| S protein of SARS-CoV-2 in complex bound with P5A-1B6_2B |
Heteromer P01594; P0DP02; P0DTC2; Q8TCD0; | 92.68 | 21×NAG; 28×NAG; | |||
| S protein of SARS-CoV-2 in complex bound with P5A-2G9 |
Heteromer A0A5C2GMM2; P01772; P0DTC2; Q8N5F4; | 93.5 | 21×NAG; 28×NAG; | |||
| S protein of SARS-CoV-2 in complex bound with P2B-1A10 |
Heteromer A0A5C2GF00; P01594; P0DTC2; Q8TCD0; | 60.0 | 21×NAG; 28×NAG; | |||
| S protein of SARS-CoV-2 in complex bound with P5A-1B6_3B |
Heteromer P01594; P0DP02; P0DTC2; Q8TCD0; | 92.68 | 20×NAG; 31×NAG; | |||
| Cryo-EM structure of the circumsporozoite protein of Plasmodium falciparum with a vaccine-elicited … |
Heteromer Q7K740; | 76.27 | ||||
| Human parainfluenza virus type 3 prefusion F trimer in complex with rPIV3-18 Fab |
Heteromer A0A059QA82; | 74.51 | ||||
| Crystal structure of RSV F bound by AM22 and the infant antibody ADI-19425 |
Heteromer A0A0B4J1V1; P03420; Q6GMX4; Q6GMX6; Q8TCD0; | 100 | ||||
| Zika Virus asymmetric unit bound with IgM antibody DH1017 Fab fragment |
Heteromer A0A024B7W1; B9A064; | 100 | ||||
| Crystal structure of SARS-CoV-2 spike stem fusion peptide in complex with neutralizing antibody COV… |
Heteromer P01834; P0DTC2; | 100 | ||||
| CryoEM structure of Hantavirus ANDV Gn(H) protein complex with 2Fabs ANDV-5 and ANDV-34 |
Heteromer P01834; Q9E006; | 100 | ||||
| Structure of IgG-Fc hexamer | homo-12-mer | 98.54 | ||||
| Crystal structure of human IgG1-Sigma Fc fragment | homo-2-mer | 97.61 | 2×NAG; | |||
| Crystal structure of a human fucosylated IgG1 Fc expressed in tobacco plants (Nicotiana benthamiana) | homo-2-mer | 100 | 2×NAG; 2×MPD; | |||
| Structure of bispecific Fc | homo-2-mer | 99.04 | 2×NAG; 5×GOL; | |||
| NNAS Fc mutant | homo-2-mer | 98.56 | 2×NAG; 2×BMA; | |||
| Fc AbVance: Increasing our knowledge of antibody structural space to enable faster and better decis… | homo-2-mer | 99.52 | 2×NAG; 3×GOL; | |||
| Crystal structure of closed conformation of human immunoglobulin Fc in presence of EndoSz | homo-2-mer | 99.03 | 1×NAG; 1×NAG; 2×CL; | |||
| Serial Femtosecond Crystallography Structure of Fc Fragment of Human IgG1 from Biosimilar VEGF-Trap | homo-2-mer | 100 | 1×NAG; 1×NAG; | |||
| Human IgG1 lacking complement-dependent cytotoxicity: hu3S193 Fc mutant K322A | homo-2-mer | 99.52 | 1×NAG; 1×NAG; 1×EDO; | |||
| Crystal structure of a human afucosylated IgG1 Fc expressed in tobacco plants (Nicotiana benthamian… | homo-2-mer | 100 | 2×NAG; | |||
| Fc mutant (K392D/K409D/D399K) | homo-2-mer | 98.56 | 1×NAG; 1×NAG; | |||
| Cryogenic Temperature Crystal Structure of Fc Fragment of Human IgG1 from Biosimilar VEGF-Trap | homo-2-mer | 100 | 1×NAG; 1×NAG; | |||
| Crystal structure of the Fc fragment of PF06438179/GP1111 an infliximab biosimilar in a C-centered … | homo-2-mer | 100 | 2×NAG; 6×ZN; 2×ACT; | |||
| Crystal structure of the Fc fragment of PF06438179/GP1111 an infliximab biosimilar in a primative o… | homo-2-mer | 100 | 1×NAG; 1×NAG; 1×K; 1×CL; | |||
| HUMAN IGG1 FC FRAGMENT, C239 INSERTION MUTANT | homo-2-mer | 99.03 | 2×NAG; 2×CYS; | |||
| IgG1 Fc Heterodimer combYSelect1 | homo-2-mer | 99.03 | 2×NAG; | |||
| Ambient Temperature Crystal Structure of Fc Fragment of Human IgG1 from Biosimilar VEGF-Trap | homo-2-mer | 100 | 1×NAG; 1×NAG; | |||
| Cryogenic Temperature Crystal Structure of Fc Fragment of Human IgG1 from Biosimilar VEGF-Trap | homo-2-mer | 100 | 1×NAG; 1×NAG; 1×GOL; | |||
| X-ray crystal structure of Fc and peptide complex | homo-2-mer | 100 | 2×NAG; 1×CL; | |||
| X-ray crystal structure of covalent-bonded complex of Fc and peptide | homo-2-mer | 100 | 2×NAG; | |||
| IgG1 Fc Heterodimer combYSelect2 | homo-2-mer | 99.52 | 2×NAG; | |||
| Crystal structure of the Fc fragment of anti-TNFa antibody infliximab (Remicade) in a primative ort… | homo-2-mer | 100 | 2×NAG; 6×ZN; 2×ACT; | |||
| Crystal structure of open conformation of human immunoglobulin Fc in presence of EndoSz | monomer | 99.05 | 1×NAG; 10×ZN; | |||
2 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 2ig2.1.B | monomer | 0.76 | 90.63 | |||
| 8a64.1.B | monomer | 0.68 | 100.00 | |||